This Research Topic will focus on perioperative issues of advanced heart failure and structural heart disease. There is a lot of focus on the procedural aspects of this field, however, what is more, critical clinically is the physiological comprehension of hemodynamics and timing of when to perform LVAD (left ventricular assist devices), TAVI (Transcatheter Aortic Valve Implantation), or Mitral clip (MC). There are many diverse types of heart failure, severe aortic stenosis, severe mitral regurgitation, and the indications for surgery and its optimal timing are especially critical issues.
It is essential to know how to take care of heart failure patients who need surgical approaches, including TAVI, Mitraclip, and LVAD, and also cannot undergo these procedures. Therefore, I would like to cover topics such as the timing of LVAD, TAVI, and MC for patients with advanced heart failure and structural heart defects, the natural history and care of patients who could not undergo even surgical operations, and the actual biomarkers in heart failure patients. In the area of severe heart failure, there is often no clear EBM because RCTs are often difficult to conduct.
For those patients' care, clinical diagnosis and clinical decisions need to be based on clinical experience. This special issue will outline diagnostic techniques for clinical diagnosis and clinical decision-making in the field of heart failure, ranging from classical biomarkers to the latest Bates theory. This special issue will also emphasize EBM, but will also focus on clinical pearls without EBM. In such cases, the physiology of hemodynamics and its application to theoretical thinking will be important. In determining the optimal time for surgery, questions such as how hemodynamics change before and after surgery, how long the patient's life expectancy is at that point, and whether other organ functions can be preserved are extremely important. We hope that this special issue will be able to address a wide range of these issues.
This Research Topic will focus on perioperative issues of advanced heart failure and structural heart disease. There is a lot of focus on the procedural aspects of this field, however, what is more, critical clinically is the physiological comprehension of hemodynamics and timing of when to perform LVAD (left ventricular assist devices), TAVI (Transcatheter Aortic Valve Implantation), or Mitral clip (MC). There are many diverse types of heart failure, severe aortic stenosis, severe mitral regurgitation, and the indications for surgery and its optimal timing are especially critical issues.
It is essential to know how to take care of heart failure patients who need surgical approaches, including TAVI, Mitraclip, and LVAD, and also cannot undergo these procedures. Therefore, I would like to cover topics such as the timing of LVAD, TAVI, and MC for patients with advanced heart failure and structural heart defects, the natural history and care of patients who could not undergo even surgical operations, and the actual biomarkers in heart failure patients. In the area of severe heart failure, there is often no clear EBM because RCTs are often difficult to conduct.
For those patients' care, clinical diagnosis and clinical decisions need to be based on clinical experience. This special issue will outline diagnostic techniques for clinical diagnosis and clinical decision-making in the field of heart failure, ranging from classical biomarkers to the latest Bates theory. This special issue will also emphasize EBM, but will also focus on clinical pearls without EBM. In such cases, the physiology of hemodynamics and its application to theoretical thinking will be important. In determining the optimal time for surgery, questions such as how hemodynamics change before and after surgery, how long the patient's life expectancy is at that point, and whether other organ functions can be preserved are extremely important. We hope that this special issue will be able to address a wide range of these issues.
